Skip to main content
logo
BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ: BLSM · Real-Time Price · USD
16.35
+0.11 (0.68%)
At close: Aug 13, 2026, 4:00 PM EDT
17.24
+0.89 (5.44%)
After-hours: Aug 13, 2026, 7:39 PM EDT

BlossomHill Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Cash & Equivalents
116136.68100.15
Cash & Short-Term Investments
116136.68100.15
Cash Growth
-36.48%-
Prepaid Expenses
3.222.144.03
Total Current Assets
119.72138.83104.17
Property, Plant & Equipment
21.2121.651.59
Other Long-Term Assets
2.482.51.02
Total Assets
143.41162.97106.78

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Accounts Payable
5.382.310.85
Accrued Expenses
10.3113.165.4
Current Portion of Leases
0.490.010.53
Total Current Liabilities
16.1815.486.77
Long-Term Leases
22.5322.39-
Total Liabilities
38.7137.876.77

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
3.923.31.59
Retained Earnings
-156.04-135.03-74.47
Total Common Equity
-152.12-131.73-72.88
Shareholders' Equity
104.7125.1100
Total Liabilities & Equity
143.41162.97106.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Total Debt
23.0222.40.53
Net Cash (Debt)
92.98114.2899.62
Net Cash Growth
-14.72%-
Net Cash Per Share
37.3946.8743.50
Filing Date Shares Outstanding
2.642.552.29
Total Common Shares Outstanding
2.642.552.29
Working Capital
103.55123.3597.4
Book Value Per Share
-57.53-51.68-31.82
Tangible Book Value
-152.12-131.73-72.88
Tangible Book Value Per Share
-57.53-51.68-31.82
Machinery
-2.621.87
Leasehold Improvements
-0.270.1
SEC Filings: 10-K · 10-Q